LANNETT Announces sale of liquid drug manufacturing plant and other assets for $10.5 million

Author's Avatar
Mar 04, 2022

--Transaction a Key Element of Company's Plan to Streamline Operations and Reduce Costs; Proceeds Further Strengthens Cash Position--

PR Newswire